Page results
-
UCLH is considered a centre of excellence in the management of patients with Hodgkin’s and non-Hodgkin’s lymphoma.
-
The bone marrow transplant and haematopoietic stem cell transplant service at UCLH is the largest in Europe and provides a full range of transplant services.
-
UCLH is a designated Haemophilia Centre providing a 24/7 service for patients, including those needing treatment with blood products and clotting factor medications.
-
Thalassaemia is a group of inherited blood conditions where the part of the blood known as haemoglobin is abnormal.
-
This service is for travellers who have returned from the tropics within the last year who are recently unwell with conditions such as fever, bloody diarrhoea or rash.
-
For a treatment to enter everyday use – it must pass through different types of clinical trial.
-
The department of clinical parasitology offers a full range of microscopy and serology for parasites.
-
The department of medical physics and biomedical engineering provides expert physical science support to activities both within UCLH and to a wide range of external partners.
-
Pan-London Post-COVID service for children and young people
-
Address National Hospital for Neurology and Neurosurgery Basil Samuel Outpatient Department Queen Square London, WC1N 3BG How to get here Finding parking spaces anywhere near…
File results
-
FOI/2024/0703 - Neurofibromatosis type 1 treatment/ volume of medication dispensed
-
FOI/2024/0704 - Contingencies to support visitors/ patients/ contractors witnessing a distressing event
-
FOI/2024/0709 - Number of dilation and curettage operations for miscarriages 2019-2024
-
FOI/2024/0712 - Occupational health services, spend/ in-house/ outsourced 2021/22-2023/24
-
FOI/2024/0716 - Toxicological screening/ testing/ training and information to patients
-
FOI/2024/0718 - Mental health/ electronic health records software/ dermatology screening/ imaging services/ medical devices for wound care
-
FOI/2024/0719 - Tenders and prices for interpretation services
-
FOI/2024/0720 - Motion picture licensing corporation
-
FOI/2024/0721 - New biologic and targeted medications/ treatment within dermatology
-
FOI/2024/0734 - Treatment and management of patients with Lupus 2023